Navigation Links
Aethlon Medical Releases Medical Device Data Against the H1N1 Swine Flu Virus
Date:10/20/2009

SAN DIEGO, Oct. 20 /PRNewswire-FirstCall/ -- Aethlon Medical, Inc. (OTC Bulletin Board: AEMD) announced today that research studies have documented the Aethlon Hemopurifier® is effective in capturing the current pandemic strain of the H1N1 Swine Flu Virus. The Hemopurifier® is the first-in-class medical device able to selectively remove infectious viruses and immunosuppressive proteins from the bloodstream. During invitro studies, the Hemopurifier® removed 68% of H1N1 virus from blood plasma in 30 minutes, 80% of the virus in two hours, and a 96% reduction of H1N1 was observed at six hours. The studies were performed by third party researchers approved by the United States Department of Health and Human Services (HHS) to house and conduct research on the current pandemic strains of H1N1 virus.

(Logo: http://www.newscom.com/cgi-bin/prnh/20090325/LA88762LOGO-b)

"The confirmation of the same Hemopurifier® we are advancing in Hepatitis-C (HCV) care, having significant activity against H1N1 virus is quite timely when considering the evolving rate of the pandemic," stated Aethlon Chairman & CEO, Jim Joyce. At present, the 2009 H1N1 influenza virus is the predominant influenza virus in circulation in most countries worldwide. Additional information on the virus, including situational updates can be accessed online at http://www.cdc.gov/H1N1flu.

Previous studies of the Hemopurifier® also demonstrated the ability of the device to capture both the reconstructed Spanish flu of 1918 virus (1918rv) and the H5N1 avian influenza virus (Bird Flu). As an adjunct therapy, the Hemopurifier® offers to improve the benefit of antiviral drugs against highly virulent strains of influenza and provides a therapeutic option against emerging strains of influenza that are resistant to drug and vaccine therapies.

About Aethlon Medical

Aethlon Medical creates diagnostic and therapeutic device solutions for infectious disease and cancer. Our Hemopurifier® represents the first-in-class medical device to selectively adsorb viruses and immunosuppressive toxins from the bloodstream. The Hemopurifier® seeks to improve Hepatitis-C treatment outcomes and serves as a broad-spectrum treatment countermeasure against bioterror and pandemic threats. Additional information regarding Aethlon Medical can be accessed online at www.aethlonmedical.com.

Certain of the statements herein may be forward-looking and involve risks and uncertainties. Such forward-looking statements involve assumptions, known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Aethlon Medical, Inc. to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements. Such potential risks and uncertainties include, without limitation, the capability of the Hemopurifier® to reduce viral loads and other disease conditions, including H1N1 influenza, the Company's ability to raise capital when needed, the Company's ability to complete the development of its planned products, the ability of the Company to obtain FDA and other regulatory approvals permitting the sale of its products, the Company's ability to manufacture its products and provide its services, the impact of government regulations, patent protection on the Company's proprietary technology, product liability exposure, uncertainty of market acceptance, competition, technological change, and other risk factors. In such instances, actual results could differ materially as a result of a variety of factors, including the risks associated with the effect of changing economic conditions and other risk factors detailed in the Company's Securities and Exchange Commission filings.

    Contacts:

    RedChip Companies, Inc.
    Jon Cunningham
    1-800-733-2447, Ext. 107
    Jon@redchip.com

    Jim Joyce
    Chairman, CEO
    858.459.7800 x301
    jj@aethlonmedical.com

    Jim Frakes
    Senior VP Finance
    858.459.7800 x300
    jfrakes@aethlonmedical.com

SOURCE Aethlon Medical, Inc.


'/>"/>
SOURCE Aethlon Medical, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Aethlon Medical Announces Presentation of Hepatitis-C (HCV) Clinical Data at 42nd Annual American Society of Nephrology (ASN) Conference
2. Aethlon Medical to Present at the 2009 RedChip Small-Cap Investor Conference on June 16, 2009
3. Premier Research Names Bernard Sweeney as Executive Director, Medical Devices
4. Starch Medical Launches Novel Plant Sourced Surgical Hemostatic Pad
5. University Medical Pharmaceuticals Selects Jeffrey Ten as Senior Vice President, International Sales
6. ECRI Institute Sees Upward Trend in Hospital Medical Technology Evaluation Activity
7. Circle Medical Devices, Texcel Medical Merge to Form CIRTEC Medical Systems
8. Dartmouth Medical School Faculty Member and Anesthesiologist Invents Revolutionary Catheter System Designed to Increase Rate of Successful IV Insertions by 75 Percent
9. Larry King to Host 10th Annual American Friends of Rabin Medical Center Broadway on the Hudson Gala
10. ATS Medical Products Featured Prominently at European Association for Cardio-Thoracic Surgeons (EACTS) Annual Meeting
11. AbbeyMoor Medical Receives Category I CPT(R) Code for The Spanner(TM) Prostatic Stent Procedure
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/10/2017)... 10, 2017  The Corporate Whistleblower Center says, ... sleep therapy clinics to call us anytime at ... is involved in a substantial scheme to overbill ... from an employee of a medical equipment company ... to provide medical practice groups with extra generous incentives ...
(Date:5/9/2017)... , May 9, 2017  Demonstrating its ... board of directors for the Pharmaceutical Research and ... for membership. Biopharmaceutical companies will now have to ... order to be eligible to join PhRMA. ... the board is sending a clear message that ...
(Date:5/8/2017)... FLINT, Mich. , May 8, 2017  Diplomat ... WRB Communications, Inc. ("WRB"), a health care ... . WRB specializes in relationship management ... organizations. WRB will ... of Diplomat,s commercialization support services for manufacturers, biotech firms, ...
Breaking Medicine Technology:
(Date:5/19/2017)... ... ... In a continuous effort to raise awareness of autism and common toxins found ... natural and organic latex mattresses, has announced that they will donate $1 to the ... recent viral Facebook video receives, up to $10,000.00. , The luxury online ...
(Date:5/19/2017)... ... May 19, 2017 , ... DMG Productions is ... of Innovations with Ed Begley, Jr., airing fourth quarter 2017 on FOX Business. ... clean, organic dietary supplement made from naturally occurring ingredients. Innovations will enlighten viewers ...
(Date:5/19/2017)... ... May 19, 2017 , ... Springfield, Vermont-based law firm of Brady/Callahan has ... Good Reasons To Hire An Experienced Personal Injury Attorney, " the article offers insight ... injury. As the article says. if someone is injured due to another person's ...
(Date:5/19/2017)... ... May 19, 2017 , ... The Miller Agency, a ... families and business owners in the region, is embarking on a cooperative charity ... their families. , Multiple sclerosis (MS) is a demyelinating disease that affects the ...
(Date:5/19/2017)... (PRWEB) , ... May 19, 2017 , ... ... containerization, today announced a sponsorship and speaking session at the 7th Annual ... the longest-running hosted enterprise mobility and digital transformation conference whose expressed purpose is ...
Breaking Medicine News(10 mins):